A diminutive protein prompts a closer look at DNA dark matter.
Marc Pelletier traveled from Cambridge, MA to Shanghai, China, to launch new lines of research for the treatment of cancers that are common in China.
Melanoma survivor T.J. Sharpe shares why patients should know their treatment options.
Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success
The culture of volunteerism is a fundamental part of the Novartis corporate ethos. Here’s a snapshot of our efforts over the years.
Novartis opens up a path of research to protect proteins that guard against cancer.
Great progress has been made against malaria, but signs of resistance are becoming a rising concern
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.